Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress - Wikidata - wikimedia - TriplyDB

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress

http://www.wikidata.org/entity/Q24805294

about

Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded.Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Aldehydes and disturbance of carbohydrate metabolism: some consequences and possible approaches to its normalization.Microcirculation in obesity: an unexplored domain.Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients Free Radicals Scavenging Capacity, Antidiabetic and Antihypertensive Activities of Flavonoid-Rich Fractions from Leaves of Trichilia emetica and Opilia amentacea in an Animal Model of Type 2 Diabetes Mellitus.Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease.Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury.Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.Inflammatory cytokines at admission--independent prognostic markers in patients with acute coronary syndrome and hyperglycaemia.17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus.

P2860

Q21246039-CAF8D511-44D7-429A-9BB6-D40D7D718E22 Q24559986-740055F8-A5A8-47EB-B606-CCEDF53D3046 Q24791545-CF73344E-DFAB-4E33-804B-B6269EE3406D Q24793969-3AE672D7-107D-474E-BDC6-5C4FE8A2235E Q24795302-46F1A9B1-916D-4A1F-B2B2-63C31F361A9E Q24799326-26A76167-405E-4565-A61E-E4C46FD19876 Q24802772-E47D8483-DFC6-4B02-9F6A-EABD8B6BA7B2 Q24811354-ADB2A66B-3C70-44AC-945E-DBF4E1AAE3EC Q35157945-E50323BE-6048-4A46-B766-8E172C4C2AFF Q36279580-DFF8A75D-81D2-4B0D-8A33-2FEE1D6BCAB8 Q36359500-095CCC9F-9641-46FB-9A5C-9C0C10730EED Q36844820-3D4C4332-8EAC-4F0C-82BC-4C303532F470 Q37027261-893505D2-7F90-4CCD-B99C-3C3E97034A60 Q37063378-77310AEB-F75C-4FD2-8FCD-80D341CA6027 Q37588105-D84DACEB-6F13-4B67-A76F-37004A13921A Q37676401-145D298F-9169-43E8-BA1B-C516999F6CF9 Q38177693-0E2F79A8-0870-47FD-B24A-8F2ACDD8745F Q38191658-4308F506-FD83-427E-9B20-7253619D8EFC Q38222735-73C0652A-5A0D-46E9-A304-8A566B820FED Q38280565-2D0634BD-E3D2-45CC-8CC8-EF4BCBAC567C Q38354900-C69A1236-FBCC-4CA1-8BFF-D882201A9247 Q38854228-1639CA99-A8FB-4025-8718-C7AEF52CA02E Q39756273-86602DC3-D392-46AE-93A4-D0B701922535 Q46387482-12BAED2D-188C-439C-97C7-19656595E1B3 Q46442489-4754D3DD-4055-44C7-BB7E-FF7ED247DDA6 Q51360663-143430D5-71B5-40ED-A7C2-2700E76F9B98 Q51740951-84DB7C3A-79B7-4A01-9DEF-8B6E9164A3AC Q54746769-A316FC82-9A71-48F2-935F-51EAD29ADAD6

P2860

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress

http://www.wikidata.org/entity/Q24805294

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@ast

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@en

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@nl

type

label

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@ast

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@en

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@nl

prefLabel

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@ast

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@en

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@nl

P1433

Q24805294-F916BAC0-6E4E-40D0-A05C-C841DB4E8F17

P1476

Q24805294-F3CE49CF-83FA-43B0-8968-738F313B1CCB

P2093

Q24805294-49F6930C-6045-4060-A845-A66301BF1E71

Q24805294-FAE44156-2D70-4750-9C9A-CFF317EB41E4

P2860

Q24805294-0BEF6162-9D44-4458-A715-95F21F90BF6C

Q24805294-0C25129F-7D8E-482F-8C25-0465D477AB81

Q24805294-0FB861AB-B1AE-41B7-ABAE-3F0096627B4D

Q24805294-14391070-25FC-4116-B4CB-BC45787389CB

Q24805294-1492266C-EB45-4BF4-ABA6-D6B6ED6C5A9E

Q24805294-1E51089F-4F7B-474C-A875-8684732AEE23

Q24805294-2089815B-CC59-4E5F-A26F-540C9AB31006

Q24805294-270941E5-2069-43F4-B63D-225EEC635EC1

Q24805294-3A65B5F2-7D92-4FA5-B75E-128D09795230

Q24805294-5AC0962F-B703-40EE-89BF-15C72BFF85C3

P2888

Q24805294-886CE6F9-26B1-4B2F-8811-0556D462A984

P304

Q24805294-87504E56-994D-4C87-93C6-8B6FF003CE65

P31

Q24805294-109EABB8-545A-4AF8-BA10-5FEF35A3FD94

P356

Q24805294-3DC99D94-63C5-4D16-9D7C-10492BF143A4

P407

Q24805294-9B5490AE-53B8-42D5-9875-A17A2820C172

P433

Q24805294-FCA74F0A-BDE9-4FF2-92C6-75759CFC7D01

P478

Q24805294-491D3FCA-D64F-4C6D-8324-838D5D3FB582

P577

Q24805294-B6A4AF75-FFC1-46C6-A6D9-49BC02AC112C

P5875

Q24805294-852BC3C6-3187-4B37-9731-6694ECB62378

P6179

Q24805294-70714CB8-458B-4E11-81D5-6EF040232FFB

P698

Q24805294-21B65700-6EFD-4FAA-A8BC-72BB6C34CF5A

P921

Q24805294-A40F36C1-5073-47BC-A51A-04B29AF48139

Q24805294-BEAB9D5E-DE3B-451B-99F7-CDB0EA3003A4

P932

Q24805294-CBA5310E-DE43-4CB8-AE1D-6A73E780495C

P356

P1433

Cardiovascular Diabetology

P1476

Is type 2 diabetes mellitus a ...... e of NOS, NO, and redox stress

@en

P2093

Melvin R Hayden

http://www.w3.org/2001/XMLSchema#string

Suresh C Tyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

Nitric oxide synthases: structure, function and inhibition

The molecule of the year

Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.

Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix.

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Does ADMA cause endothelial dysfunction?

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.

P2888

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-2-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10864195

http://www.w3.org/2001/XMLSchema#string

P6179

1042508056

http://www.w3.org/2001/XMLSchema#string

P698

12628022

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

151667

http://www.w3.org/2001/XMLSchema#string